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1. Direct link to deposited data {#s0005}
================================

<http://www.ncbi.nlm.nih.gov/sra/?term=SRP059858>

<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55520>

<http://epigenetics.nrichd.ncchd.go.jp/ips/data/XP40OS.vcf.bz2>

<http://epigenetics.nrichd.ncchd.go.jp/ips/data/XP40OS.tsv.bz2>

2. Experimental design, materials and methods {#s0010}
=============================================

Xeroderma pigmentosum (XP) is caused by a deficiency in base excision repair, resulting in a large number of single-nucleotide mutations, especially in sun-exposed skin [@bb0005]. Due to the independent manner of the occurrence of the somatic mutations, the patient tissue, including fibroblasts, may form a high degree of mosaicism. If a mutation had occurred in an early stage of development or in stem cells, it could readily be detected by DNA sequencing. Most of the mutations that have occurred in skin cells would not be expanded much because the greater part of the cells is rather differentiated. Hence, it seems difficult to obtain a genome-wide pattern of XP-derived mutations. However, it may be possible to examine a whole set of mutations of a single cell if the cell could be cloned. This can be achieved by generation of iPS cells owing to the fact that the process is cloning *per se* [@bb0010]. One may suspect that a number of *de novo* mutations arise during the reprogramming process and cultivation after the establishment of an iPS cell line, but many recent studies have demonstrated that most of the mutations found in iPS cells were preexisting in their progenitor lines, suggesting the high genetic stability of reprogramming and subsequent cultivation [@bb0015], [@bb0020]. In the present study, we focused on a fibroblast cell line derived from an XP patient and established its iPS cell lines in order to delineate somatic mutations in the exome-target regions.

We obtained the XP40OS cell line, which was derived from a patient diagnosed with XP group C, from the JCRB Cell Bank [@bb0025]. This study was approved by the Institutional Review Board at the National Center for Child Health and Development. Employing the same method described in our previous study, we established its iPS cell line and performed whole-exome sequencing and structural alteration analyses for both the progenitor and iPS cell lines [@bb0030]. In brief, the iPS cells were generated by reprogramming with Sendai virus infection-mediated expression of the four factors. Extracted DNA samples were treated with Agilent SureSelect Human All Exon V4 + UTRs + lincRNA, whose target size was approximately 80 Mb, to prepare a pair-end library. The library was sequenced on the Illumina platform, yielding 18.8 Gb (93.3 M read pairs) and 18.7 Gb (92.7 M read pairs) data, respectively. After trimming, the data sizes were reduced to 16.9 Gb (84.3 M read pairs) and 16.8 Gb (83.7 M read pairs). For both samples, over 99% bases had q-scores that are more than 15. Our pipeline software included cutadapt-1.7.1, BWA 0.7.12, SAMtools 1.2, Picard 1.130, Genome Analysis Toolkit 3.3, and our own custom programs coded in C or Perl. Reads were mapped to the hs37d5 (GRCh37) reference sequence and PCR duplicate reads were then eliminated. Ratios of PCR duplicates were 27.4% and 26.5%, respectively. Along with in-house control data, multi-sample calling of single-nucleotide and short indel variations was performed. Filtration and identification of somatic mutations were carried out as described in our previous study [@bb0030].

First, we searched for possible variants that could affect the XP phenotype. Such variants should be found in both lines. A homozygous one (rs1800975) was found in the 5′ untranslated region of the *XPA* gene and two heterozygous ones (rs2228000 and rs2228001), which alter amino acid sequences, were found in the protein-coding regions of the *XPC* gene. Since their allelic frequencies in the population were not rare (50.8%, 32.6%, and 60.6%, respectively, according to the Human Genetic Variation Database, <http://www.genome.med.kyoto-u.ac.jp/SnpDB>), they cannot be considered as etiologic variants. While we failed to find any other notable variants in XP-related genes, we found homozygous deletions in the *BTNL3*, *GSTM1*, *GSTT1*, and *SLC25A24* loci. The *GSTM1* and *GSTT1* genes lacked the entire coding regions. The list of all possible variants is available from the websites (see the "[Direct link to deposited data](#s0005){ref-type="sec"}" section).

Next, we searched for inconsistent genotypes called with UnifiedGenotyper between the progenitor and its iPS cell lines to identify somatic mutations. Using the criteria described in our previous study [@bb0030], 922 single-nucleotide substitutions and 77 indels were identified. Because the numbers were extremely high compared to those of the preceding studies, we examined the positions of all the genotypes that exhibited disagreement between the two lines ([Fig. 1](#f0005){ref-type="fig"}). Among these sites, 845 single-nucleotide and 69 indel sites were located on the long arm of chromosome 9. All the called genotypes were homozygous without exception. Using an Illumina HumanCytoSNP-12 v2.1 DNA Analysis BeadChip Kit, we also performed a SNP-genotyping analysis to examine the existence of structural alterations. Copy-neutral loss of heterozygosity was detected in the 9:71,035,938--138,893,874 region (GRCh37) of the iPS cell line, indicating that a large structural mutation formed uniparental disomy. In that case, heterozygous sites in the region became homozygous. The 914 sites in the exome-target regions were considered to be just heterozygous in the progenitor cell, but not individual mutations. The SNP-genotyping analysis also suggested one copy-gain mutation around 16:83,939,438--85,567,156 only in the iPS cell line, but no genotype disagreement was found in this 1.6-Mb region. Among the remaining 77 single-nucleotide substitutions, C-to-T or G-to-A transitions accounted for 29 of the changes.

3. Discussion {#s0015}
=============

It is well known that C-to-T or G-to-A transitions in a dipyrimidine context are typical type of UV-specific mutations [@bb0035]. A trinucleotide analysis revealed that TCT, TCC, TCA, and their complementary trinucleotides, in which the mutated base is situated in the center, are frequently subject to mutation. Partially due to the relatively low number of mutations, the significance of the mutation type in the sample was not determined. In addition to the fact that we failed to find crucial mutations in XP-related genes in the exome-target regions, the donor of the fibroblast might be affected by another type of XP. It could be possible that some of the mutations that we identified in both of the lines are responsible for the phenotype.
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![Genome-wide distribution of the somatic mutations identified in the present study.\
Blue and red bars indicate single-nucleotide and indel mutations, respectively. Nearly one thousand mutations were detected on the long arm of chromosome 9. The discrepant genotypes between the progenitor and its iPS cell lines were caused by a single structural mutation that formed uniparental disomy in the chromosome arm.](gr1){#f0005}
